Treatment of Cellulite and Local Obesity by a Treatment of Cellulite and Local Obesity by Acoustic Waves (Awt): Presentation of Three Cases and the Protocol Used
Ferial Fanian1, Hamed
Zartab2, Taraneh Yazdanparast2,3, Zeynab Variji2,
Ali Rajabi Estarabadi2, Alireza Firooz2,4
1Center for Studies and Research
on the Integument (CERT), Department of Dermatology, University hospital of
Besançon, France
2Pharmaceutical, Cosmeceutical and
Hygienic Products Clinical Evaluation Lab (Derma Lab), Centre for Research and
Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences,
Tehran, Iran
3Chronic Respiratory Diseases
Research Centre, National Research Institute of Tuberculosis and Lung Diseases
(NRITLD), Shahid Beheshti University of Medical Sciences, Air pollution, health
and occupational diseases research unit, Tehran, Iran
4Cosmetic Products Research
Centre, Food and Drug Organization, Tehran, Iran
*Corresponding
author: Alireza Firooz, Centre for
Research, Training in Skin Diseases & Leprosy, Tehran University of Medical
Sciences, 415 Taleghani Avenue, Tehran, postal code: 1416613675 Telephone:
(98-21) 88960880, 88978190; Fax: (98-21) 88963804, 8897819; Email: firozali@sina.tums.ac.ir
Received Date: 20 October, 2016; Accepted Date: 30 November, 2016; Published Date: 05 December, 2016
Citation: Fanian F, Zartab H, Taraneh Yazdanparast T, Variji Z, Estarabad AR, et al. (2016) “Treatment of Cellulite and Local Obesity by a Treatment of Cellulite and Local Obesity by acoustic Waves (Awt): Presentation of Three Cases and the Protocol Used” Dermatology Research and Therapy GDRT -113. DOI: 10.29011/2575-8268/100013
There are different ways to treat local
obesity and cellulite including invasive and noninvasive methods. Due to the
fact that non-invasive methods have significantly lower rates of adverse
effects, they have been becoming more popular. One of these methods is Acoustic
Wave Therapy (AWT) or Shock Wave Therapy (SWT). In addition to treating
cellulite, SWT has been found useful for some other conditions. In this paper,
we briefly introduce SWT and describe the protocol and results of treating
cellulite and local obesity using Cellactor® SC1 device (Storz
Medical, Switzerland) in three females with normal body mass indices.
Keywords: Obesity; Cellulite; Acoustic wave; Body mass index; Non
invasive liposuction; Body contouring
1. Introduction
Available treatments for body contouring
(body-sculpting) are divided in two groups: invasive and non-invasive. Invasive
treatments potentially have some risks [1]. Despite this; invasive Lipoplasty
is the most common method that is used for body-sculpting in the U.S.A yet. Due
to potential complications of invasive methods, tendency for use of
non-invasive methods is enhancing increasingly. There are different
non-invasive methods for body-sculpting such as treatment by radio frequency
waves, cryolipolysis, treatment by low power laser, injection lypolysis, low
intensity non thermal ultrasound, high intensity focal ultrasound. Non-invasive
treatments have fewer complications and don’t need local and general
anaesthesia or need less. Non-invasive methods are ideal for patients with
moderate to severe overweight and done with the aim of reducing fat tissue in
moderate amount. [2] One of the non-invasive treatments is acoustic wave
therapy (AWT) or shock wave therapy (SWT). AWT consists of producing pulses
that are applied on skin surface mechanically and penetrate subcutaneous
tissue. Both low and high amplitude microwaves have treatment effects. SWT have
been used in different fields such as: orthopaedics (plantar Fasciitis,
shoulder tendinosis calcarea, aseptic necrosis …).
Rehabilitation and pain management, treatment
of chronic ulcerative Cutaneous lesions, scars (such as burning scars),
cardiology (myocardial ischemia) and infectious diseases (with anti-bacterial
role) [3-7].
2. Case
presentation and protocol
Results of three out patients cases treatment by Cellactor® SC1
system manufactured by Storz Medical company from Switzerland in a specialist
dermatology clinic are presented in this article. This device has three probes
with the names of C-Actor®, D-Actor® and V-Actor®
that any of them apply the waves to the surfaces under treatment in a different
method. D-Actor® has radial pulses and C-Actor® has
planar pulses. V-Actor® is actually a local vibrator. Treatment
protocol is the adjusted version of the protocol proposed by Storz Medical
Company which has been designed by physicians of that clinic according to their
clinical experiment and any patient’s treatment response and possible
complications. Considering the Physician’s clinical judgment, patients’
treatment response, complications of any probe and three factors of frequency,
energy and number of pulses of the waves for any region under treatment,
Flexibility in the implementation of the Protocol should set by the Physician.
All patients were between 30 and 45 years of age, their BMIs were normal and
all of them attended in any treatment sessions.
2.1. First case:
The first case was a 38 years old female with the weight of 56
kg and the height of 159 cm (BMI=22.15) who was treated twice a week and
totally nine sessions. Areas under treatment were love handles. Frequency,
energy and number of pulses for any area, treatment session and probe have been
shown in [Tables 1-3].
The patient lost weight 1.8 kg by 32 days after beginning the
treatment (from 56 kg to 54.2 kg). Measurements of the abdominal circumference
were done in three levels according to the (Figure 1).
Measures of abdominal circumference in level A by 0, 11 and 32
days after beginning the treatment were 84, 81 and 78.5 cm respectively
(totally 5.5 cm reduction of the circumference). Measures of abdominal
circumference in level B by 0, 11 and 32 days after beginning the treatment
were 87, 86 and 85 cm respectively (totally 2 cm reduction of the
circumference). Measures of abdominal circumference in level C by 0, 11 and 32
days after beginning the treatment were 74, 71 and 70 cm respectively (totally
4 cm reduction of the circumference). Total results after completion the
treatment are shown in (Figure 2).
2.2. Second
case:
The second case was a 45 years old female with the weight of 66
kg and the height of 167.5 cm (BMI=23.52) who was treated twice a week and
totally nine sessions. Areas under treatment were anterior and posterior parts
of both thighs. Frequency, energy and number of pulses for any area, treatment
session and probe have been shown in [Tables 4-6].
The patient lost weight 4 kg by 32 days after beginning the
treatment (from 66 kg to 62 kg). Measurements of the right and left thighs were
done in three levels according to the (Figure 3).
Measures of right thigh circumference in level A by 0, 15 and 36
days after beginning the treatment were 51, 48.5 and 48 cm respectively
(totally 3 cm reduction of the circumference). Measures of right thigh
circumference in level B by 0, 15 and 36 days after beginning the treatment
were 58, 55.5 and 54 cm respectively (totally 4 cm reduction of the circumference).
Measures of the circumference in level C by 0, 15 and 36 days after beginning
the treatment were 62, 59 and 57 cm respectively (totally 5 cm reduction of the
circumference). Total results after completion the treatment are shown in
(Figure 4).
2.3. Third case:
The third case was a 42 years old female with the weight of 57
kg and the height of 160 cm (BMI=22.26) that was treated twice a week and
totally ten sessions. Areas under treatment were anterior and posterior parts
of both thighs. Frequency, energy and number of pulses for any area, treatment
session and probe have been shown in [Tables 7-9].
The patient lost weight 3 kg by 32 days after beginning the
treatment (from 57 kg to 54 kg). Measurements of the right and left thighs were
done in three levels according to the (Figure 5).
Measures of the right thigh circumference in level A by 0, 8, 22
and 47 days after beginning the treatment were 60, 60, 58 and 57 cm
respectively (totally 3 cm reduction of the circumference). Measures of right
thigh circumference in level B by 0, 8, 22 and 47 days after beginning the
treatment were 57, 58, 56 and 54 cm respectively (totally 3 cm reduction of the
circumference). Measures of the circumference in level C by 0, 8, 22 and 47
days after beginning the treatment were 101, 99, 97 and 95 cm respectively
(totally 6 cm reduction of the circumference). Total results after completion
the treatment are shown in (Figure 6).
3. Discussion
Cellulite is much more prevalent in women than men because of
Greater number of fat cells in women and different ways of fat storage in two
sexes [8]. Several factors are involved in the development of Cellulite
and lipedema. These factors include the following. increase and accumulation of
fat in dermal tissue of the thigh and buttock, thinning of collagen layers because
of aging (this process is accelerated by menopause and makes epidermis loose
and subcutaneous tissue tighter) [8-10], free radicals, sun rays, inadequate
diet, stress, smoking, obesity, Impaired lymphatic flow due to a sedentary life
style, Fibrosis due to the accumulation of plasma proteins in the interstitial
tissue [8].
Cellulite has 4
stages:
Stage 0 : when the skin is pinched there is no dimpling.
Stage 1 : there is no dimpling by itself; some cellulite is visible when
the skin is pinched.
Stage 2 : there is dimpling when standing but there is not when
lying down.
Stage 3 : dimpling is seen when both standing and lying down [12].
Treatment response is usually significant in
0th and 1th stage, partial in 2th stage and stage 3 is refractory to the
treatment.
Known or proposed effects of AWT
consist of the following items:
Improvement of the perfusion, increase of cell proliferation and
regeneration and improvement of tissue quality [3-5], [13-14] , increase of fat
mobilization and lipolysis in edematous area [15], increase in serum
concentration of malondialdehyde (MDA) and plasma protein carbonyls which shows
reduction of oxidative stress [16], rise of cell membrane permeability [17-18],
increase of mitochondrial endoplasmic reticulum cytoskeleton waste permeability
[19], stem cells stimulation [20], Increased release of growth factors such as
TGF- ß1 and VEGF, stimulation of enzymes such as endothelial nitric oxide
synthetase and Proliferation of cell nuclear antigen [16, 21-23]. Induction of
intra and extra cellular signals transmission and production of Nitroxide
radicals and heat shock proteins [24], collagen rearrangement [25], cavitation
effect [26], Stimulation of microcirculation in blood and lymphatic vessels
[27], release of substance P [28], anti-bacterial effect [6], improved
biomechanical properties of the skin and as a result softening and improving
the appearance of the skin [16], Improving skin elasticity and patients’
satisfaction with treatment that can continue even longer than 6 months [29-30].
In addition to being non-invasive, AWT cellulite treatment has
some other advantages such as: Easy to use, very low complications and short
courses.
In a study of 18 to 65 years old females with
varying degrees of cellulite six different criteria were used to evaluate the
results of treatment with AWT that were consisted of: photonomeric severity
scale, Nürnberger scale, measuring the circumference, capillary blood flow,
Tissue oxygen saturation and after capillary venous blood flow. In this
triple-blind controlled clinical trial, a placebo or sham? AWT was performed
(by a special hand piece designed for this purpose) for the control group in
the gluteal region and thigh at six sessions. In addition, a special
strengthening exercise for the gluteal muscles was recommended. For the case
group AWT was performed in the gluteal region and thigh at six sessions. In
addition, a special strengthening exercise for the gluteal muscles was
recommended.
The participants were followed for 12 weeks.
AWT was much more effective to treat cellulite in comparison with
“strengthening the gluteus muscles program” method alone [31]. A study which
used combination technology of cryolipolysis and AWT for non-invasive body
contouring showed that AWT and cryolipolysis had synergistic effect. The mean
reduction in fat thickness in this study was 3.02 cm, circumference of treated
area had decreased an average of 4.45 cm and cellulite and blood flow to the
area were improved significantly too [32].
Both planar and radial AWT were used in
another investigation. Saddle bag areas of 14 females were treated twice a week
for 4 weeks and results of treatment were assessed 1, 4 and 12 weeks after end
of the treatment. Ultrasound evaluation of treated area showed significant
reduction in the thickness of the subcutaneous fat layer. Mean circumference of
treated thighs reduced too [33].
In another study [30], patients were divided
in three groups: first group got only radial treatment (11 patients), second
group got only planar treatment (9 patients) and third group got both radial
and planar treatment (7 patients). Results were evaluated by scale of 0-10
(0-3.9 meant no change, 4-5.9 Satisfactory change and 6-10 ideal change). The
means of recovery scores were 5.5, 3.3 and 4.3 in first, second and third group
respectively. In first group, 5 patients showed ideal and 3 ones showed
satisfactory results and patients reported cellulite improvement after an
average of 2.5 sessions. In second group, 1 patient showed ideal and 5 ones
showed satisfactory results. 50% of patients in this group reported cellulite
improvement after an average of 3.8 sessions. In third group, 2 patients showed
ideal and 4 ones showed satisfactory results and 7 patients in this group
reported cellulite improvement after an average of 3.6 sessions. There were no
adverse effects in these three groups and there were no obvious and significant
change in skin elasticity either.
In treatment of cellulite, it should be considered that collagen
regeneration and synthesis is a time taking process and due to that while
treating by AWT, significant recovery shouldn’t be expected immediately after
any treatment session. Improvement process will continue even until a few
months after treatment sessions (that are often between 8 to 10 sessions) [34].
There are different ways to evaluate response to the treatment
after performing AWT that include: photonomeric scale, Nürnberger scale,
measurement of area circumference, amount of area capillary blood flow, tissue
oxygen saturation and amount of after capillary blood flow [31].
4. Conclusion
Treatment of cellulite and local obesity by AWT can be an
effective method in decreasing size and grade of cellulite if an appropriate
patient is chosen based on age and BMI and regular follow up is performed.
Figure 1: Measured regions to assess response to the treatment in first patient.
Figure 2: Anterior and posterior view of region under treatment in first patient by 0 (upper photos), (15 middle photos) and 30 (Bottom photos) days after beginning the treatment.
Figure 3: Measured regions to assess response to the treatment in second patient.
Figure 4: Anterior and posterior view of region under treatment in second patient by 0 (upper photos) and 36 (Bottom photos) days after beginning the treatment.
Figure 5: Measured regions to assess response to the treatment in third patient.
Figure 6: Posterior and lateral view of region under treatment in third patient by 0 (upper photos) and 47 (Bottom photos) days after beginning the treatment.
Parameter/visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
Frequency |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
Energy |
0.76 |
0.88 |
1.02 |
1.02 |
1.24 |
1.24 |
1.24 |
1.24 |
1.24 |
Number of pulses for any region under treatment |
1000 |
1000 |
1000 |
2000 |
1000 |
1000 |
1000 |
1000 |
1000 |
Table 1: probe C-Actor® Treatment protocol of probe C-Actor® in any visit for first patient.
Parameter/visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
Frequency |
16 |
16 |
16 |
16 |
14 |
14 |
15 |
15 |
15 |
Energy |
4 |
4.2 |
4.4 |
4.6 |
4.8 |
4.8 |
5 |
5 |
5 |
Number of pulses for any region under treatment |
1500 |
1500 |
1500 |
2000 |
2000 |
2000 |
2000 |
2000 |
2000 |
Table 2: Treatment protocol of probe D-Actor® in any visit for first patient.
Parameter/visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
Frequency |
35 |
35 |
35 |
35 |
35 |
35 |
35 |
35 |
35 |
Energy |
4 |
4 |
4 |
4 |
4 |
4 |
4 |
4 |
4 |
Number of pulses for any region under treatment |
2500 |
2500 |
2500 |
2500 |
2500 |
2500 |
2500 |
2500 |
2500 |
Table 3: Treatment protocol of probe V-Actor® in any visit for first patient.
Parameter/visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
Frequency |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
Energy |
1.02 |
1.24 |
1.24 |
1.24 |
1.24 |
1.24 |
1.24 |
1.24 |
1.24 |
Number of pulses for any region under treatment |
1500 |
1500 |
1500 |
1500 |
1500 |
1500 |
1500 |
1500 |
1500 |
Table 4: Treatment protocol of probe C- Actor® in any visit for second patient.
Parameter/visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
Frequency |
14 |
14 |
14 |
14 |
14 |
14 |
14 |
14 |
14 |
Energy |
3 |
4 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
Number of pulses for any region under treatment |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
Table 5: Treatment protocol of probe D- Actor ® in any visit for second patient.
Parameter/visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
Frequency |
35 |
35 |
35 |
35 |
35 |
35 |
35 |
35 |
35 |
energy |
4 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
Number of pulses for any region under treatment |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
Table 6: Treatment protocol of probe V- Actor ® in any visit for second patient.
Parameter/visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
frequency |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
energy |
0.88 |
1.02 |
1.24 |
1.24 |
1.24 |
1.24 |
1.24 |
1.24 |
1.24 |
Number of pulses for any region under treatment |
1500 |
1500 |
1500 |
1500 |
1500 |
1500 |
1500 |
1500 |
1500 |
Table 7: Treatment protocol of probe C- Actor® in any visit for third patient.
Parameter/visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
frequency |
12 |
12 |
14 |
14 |
14 |
14 |
14 |
14 |
14 |
energy |
4 |
4.2 |
4.6 |
4.8 |
5 |
5 |
5 |
5 |
5 |
Number of pulses for any region under treatment |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
5000 |
Table 8: Treatment protocol of probe D-Actor® in any visit for third patient.
Parameter/visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
Visit |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
frequency |
35 |
35 |
35 |
35 |
35 |
35 |
35 |
35 |
35 |
energy |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
Number of pulses for any region under treatment |
4 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
Table 9: Treatment protocol of probe V-Actor® in any visit for third patient.
- Moreno-Moraga J, Valero-Altés T, Riquelme AM, Isarria-Marcosy MI, De la Torre JR (2007) “Body contouring by non-invasive transdermal focused ultrasound”. Lasers Surg Med 39: 315-323.
- Jewell ML, Solish NJ, Desilets CS (2011) “Noninvasive body sculpting technologies with an emphasis on high-intensity focused ultrasound”. Aesthetic Plast Surg 35: 901-912.
- Wang CJ (2003) “An overview of shockwave therapy in musculoskeletal disorders” Chang Gung Med J 26: 220-232.
- Fioramonti P, Cigna E, Onesti MG, Fino P, Fallico N, Scuderi N (2012) “Extracorporeal shock wave therapy for the management of burn scars”. Dermatol Surg 38: 778-782.
- Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, et al (2004) “Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia induced myocardial dysfunction in pigs in vivo” Circulation 110: 3055-3061.
- Gollwitzer H, Horn C, Von Eiff C, Henne M, Gerdesmeyer L, et al. (2004) “Antibacterial effectiveness of high-energetic extracorporeal shock waves: an in vitro verification”. Z OrthopIhr Grenzgeb 142: 462-466.
- Angehrn H, Kuhn C, Voss A (2007) “Can cellulite be treated with low-energy extracorporeal shock wave therapy?” Clin Interv Aging 2: 623-630.
- Voss W and Siebrecht S (2005) Gesunde haut. Trias Verlag 102 ff.
- Busch S (1976) “Vergleichende Untersuchun gender bindegewebigen Binnenstrukturen des Oberschenkels von Männernund Frauen” Mainz University. Med Diss.
- Dini G, Ghersetich I, Grappone C, Lotti T, et al. (1990) “Proteoglycans in so-called cellulite”. Int J Dermatol 20: 272-274.
- Weisselder H and Schuchhardt C (2000) “Erkrankungen des lemphgefäßsystems”. Viavital Verlag.
- Nürnberger F and Müller G (1978) “So-called cellulite: An invented disease”. J Dermatol Surg Oncol 4: 221-229.
- Meirer R, Kamelger FS, Huemer GM (2005) “Extracorporeal shock wave may enhance skin flap survival in an animal model” Br J Plastic Surg 58: 53-57.
- Haupt G, Chavpil M (1990) “Effect of shock waves on the healing of partial-thickness wounds in piglets” J Surg Res 49: 45-48.
- Faga A, Valdatta L, Mezzetti M, Buoro M, Thione A (2002) “Ultrasound-assisted lipolysis of the omentum in dwarf pigs” Aesthetic Plast Surg 26: 193-196.
- Siems W, Grune T, Voss P, Brenke R (2005) “Anti-fibrosclerotic effects of shock wave therapy in lipedema and cellulite” BioFactors 24: 275-282.
- Byron CR, Benson BM, Stewart AA, Stewart MC (2005) “Effects of radial shock waves on membrane permeability and viability of chondrocytes and structure of articular cartilage in equine cartilage explants” Am J Vet Res 2005;66:1757-1763.
- Koshiyama K, Kodama T, Yano T, Fujikawa S (2006) “Structural change in lipid bilayers and water penetration induced by shock waves: Molecular dynamics simulations” Biophys J 91: 2198-2205.
- Moosavi-Nejad SF, Hosseini SHR, Satoh M, Takayama K (2006) “Shock wave induced cytoskeletal and morphological deformations in a human renal carcinoma cell line” Cancer Science 97: 296-304.
- Delhasse Y, Neuland H, Bloch W (2009) “Influence of focused and radial shock wave treatment on the behaviour of human mesenchymal stem cells (MSCs) in the range of tissue repair”. 10th ISMST Congress, Sorrento 195.
- Chan YJ, Wurtz T, Wang CJ, Kuo YR, Yang KD et al. (2004) “Recruitment of mesenchymal stem cells and expression of TGF-ß1 and VEGF in the early stages of shockwave promoted bone regeneration of segmental defects in rats” J Orthop Res 22: 526-534.
- Wang CJ, Wang FS, Yang KD (2008) “Biological effects of extracorporeal shockwave in bone healing: a study in rabbits” Arch Orthop Trauma Surg 128: 879-884.
- Oi K, Fukumoto Y, Ito K, Uwatoku T, Abe K et al. (2008) “Extracorporeal shock wave therapy ameliorates hind limb ischemia in rabbits”. Tohoku J Exp Med 214: 151-158.
- Neuland H, Kesselman-Evans Z, Duchstein H-J, et al. (2004) “Outline of the Molecular biological Effects of the Extracorporal Shockwaves (ESW) on the human organism.” Orthopädische Praxis 9: 488-492.
- Palmieri B, Capone S. (2010) “Cavitazione rimodellamento corporeo: efficacia e sicurezza degli ultrasuoni” Hitech Dermatology 1: 37-44.
- Chan H, Bryman A, Matula T (2009) “High speed micro-cinematography of cavitation in blood vessels” 10th ISMST Congress, Sorrento.
- Mariotto S, Cavalieri E, Amelio E, et al. (2005) “Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production” Nitric- Oxide 12: 89-96.
- Maier M, Averbeck B, Milz S, RefiorHJ, Schmitz C (2003) “Substance P and prostaglandnn E2 release after shock wave application to the rabbit femur” Clin Orthop J 406: 237-245.
- Christ C, Brenke R, Sattler G, Siems W, Novak P et al. (2008) “Improvement in skin elasticity in the treatment of cellulite and connective tissue weakness by means of extracorporal pulse activation therapy” Aesthetic Surg J 5: 538-544.
- Sattler G, Pohl U, Raegener K. (2008) “Pilotstudieakustische Wellentherapie (AWT) bei Cellulite” Äestetische Dermatologie 2: 16-25.
- Knobloch K, Joest B, Vogt PM. (2010) “Cellulite extracorporeal shockwave therapy (CelluShock-2009) – a randomized trial”. BMC Women’s Health 10:29.
- Ferraro GA, De Francesco F, Cataldo C, Rossano F, Nicoletti G et al. (2012) “Synergistic effects of cryolipolysis and shock waves for noninvasive body contouring” Aesthetic Plast Surg 36: 666-679.
- Adatto MA, Adatto-Neilson R, Novak P, Krotz A, Haller G (2011) “Body shaping with acoustic wave therapy AWT(®)/EPAT(®): randomized, controlled study on 14 subjects”. J Cosmet Laser Ther 13: 291-296.
- Novak P (2009) “Acoustic wave therapy for treating cosmetic disorders. 15th World Congress of IPRAS” New Delhi, India.